Proton Radiation Therapy - Revision history

Lazy at 08:25, 18 January 2025

2025-01-18T08:25:08Z

← Older revision		Revision as of 01:25, 18 January 2025
Line 15:		Line 15:
	\|toxicity_explanation=While acute radiation-related toxicities were equivalent to conventional radiation therapy, PBT has a higher prevalence of radiation necrosis, indicating a need for careful patient selection and management.		\|toxicity_explanation=While acute radiation-related toxicities were equivalent to conventional radiation therapy, PBT has a higher prevalence of radiation necrosis, indicating a need for careful patient selection and management.
	\|book_text=Proton Beam Therapy (PBT) represents a more targeted form of radiation therapy for glioblastoma, distinguished by its use of protons instead of traditional photons. This method allows for precise targeting of the tumor, minimizing damage to surrounding brain tissue. Research indicates that high-dose PBT can offer significant survival advantages over conventional radiation therapy, although it comes with a higher risk of radiation necrosis. Recent studies have explored the efficacy and safety of PBT, highlighting its potential to improve patient outcomes while also noting the importance of addressing associated toxic...		\|book_text=Proton Beam Therapy (PBT) represents a more targeted form of radiation therapy for glioblastoma, distinguished by its use of protons instead of traditional photons. This method allows for precise targeting of the tumor, minimizing damage to surrounding brain tissue. Research indicates that high-dose PBT can offer significant survival advantages over conventional radiation therapy, although it comes with a higher risk of radiation necrosis. Recent studies have explored the efficacy and safety of PBT, highlighting its potential to improve patient outcomes while also noting the importance of addressing associated toxic...
	}}		\|overview=Proton Beam Therapy (PBT) is an FDA-approved, targeted radiation treatment for glioblastoma and other cancers, offering potential survival advantages with improved progression-free survival rates compared to traditional therapies. While PBT minimizes damage to surrounding tissues, it is associated with a higher risk of radiation necrosis, necessitating careful patient selection and management.}}

Lazy at 03:06, 18 November 2024

2024-11-18T03:06:37Z

← Older revision		Revision as of 20:06, 17 November 2024
Line 12:		Line 12:
	\|toxicity_level=3		\|toxicity_level=3
	\|treatment_category=Radiation		\|treatment_category=Radiation
			\|category=Radiation
	\|toxicity_explanation=While acute radiation-related toxicities were equivalent to conventional radiation therapy, PBT has a higher prevalence of radiation necrosis, indicating a need for careful patient selection and management.		\|toxicity_explanation=While acute radiation-related toxicities were equivalent to conventional radiation therapy, PBT has a higher prevalence of radiation necrosis, indicating a need for careful patient selection and management.
	\|book_text=Proton Beam Therapy (PBT) represents a more targeted form of radiation therapy for glioblastoma, distinguished by its use of protons instead of traditional photons. This method allows for precise targeting of the tumor, minimizing damage to surrounding brain tissue. Research indicates that high-dose PBT can offer significant survival advantages over conventional radiation therapy, although it comes with a higher risk of radiation necrosis. Recent studies have explored the efficacy and safety of PBT, highlighting its potential to improve patient outcomes while also noting the importance of addressing associated toxic...		\|book_text=Proton Beam Therapy (PBT) represents a more targeted form of radiation therapy for glioblastoma, distinguished by its use of protons instead of traditional photons. This method allows for precise targeting of the tumor, minimizing damage to surrounding brain tissue. Research indicates that high-dose PBT can offer significant survival advantages over conventional radiation therapy, although it comes with a higher risk of radiation necrosis. Recent studies have explored the efficacy and safety of PBT, highlighting its potential to improve patient outcomes while also noting the importance of addressing associated toxic...
	}}		}}

Lazy at 18:41, 12 November 2024

2024-11-12T18:41:38Z

← Older revision		Revision as of 11:41, 12 November 2024
Line 11:		Line 11:
	\|usefulness_rating=4		\|usefulness_rating=4
	\|toxicity_level=3		\|toxicity_level=3
			\|treatment_category=Radiation
	\|toxicity_explanation=While acute radiation-related toxicities were equivalent to conventional radiation therapy, PBT has a higher prevalence of radiation necrosis, indicating a need for careful patient selection and management.		\|toxicity_explanation=While acute radiation-related toxicities were equivalent to conventional radiation therapy, PBT has a higher prevalence of radiation necrosis, indicating a need for careful patient selection and management.
	\|book_text=Proton Beam Therapy (PBT) represents a more targeted form of radiation therapy for glioblastoma, distinguished by its use of protons instead of traditional photons. This method allows for precise targeting of the tumor, minimizing damage to surrounding brain tissue. Research indicates that high-dose PBT can offer significant survival advantages over conventional radiation therapy, although it comes with a higher risk of radiation necrosis. Recent studies have explored the efficacy and safety of PBT, highlighting its potential to improve patient outcomes while also noting the importance of addressing associated toxic...		\|book_text=Proton Beam Therapy (PBT) represents a more targeted form of radiation therapy for glioblastoma, distinguished by its use of protons instead of traditional photons. This method allows for precise targeting of the tumor, minimizing damage to surrounding brain tissue. Research indicates that high-dose PBT can offer significant survival advantages over conventional radiation therapy, although it comes with a higher risk of radiation necrosis. Recent studies have explored the efficacy and safety of PBT, highlighting its potential to improve patient outcomes while also noting the importance of addressing associated toxic...
	}}		}}

Lazy at 17:00, 29 March 2024

2024-03-29T17:00:29Z

← Older revision		Revision as of 10:00, 29 March 2024
Line 9:		Line 9:
	\|PFS_without=Standard radiation therapy PFS rates are lower compared to PBT		\|PFS_without=Standard radiation therapy PFS rates are lower compared to PBT
	\|PFS_with=Improved PFS observed with PBT, specific rates vary by study		\|PFS_with=Improved PFS observed with PBT, specific rates vary by study
	\|usefulness_rating=4 ~~(Based on potential for increased survival and precision in targeting tumors while sparing surrounding tissue)~~		\|usefulness_rating=4
	\|toxicity_level=3 ~~(Higher incidence of radiation necrosis noted, which may require surgical intervention or medical treatment with bevacizumab)~~		\|toxicity_level=3
	\|toxicity_explanation=While acute radiation-related toxicities were equivalent to conventional radiation therapy, PBT has a higher prevalence of radiation necrosis, indicating a need for careful patient selection and management.		\|toxicity_explanation=While acute radiation-related toxicities were equivalent to conventional radiation therapy, PBT has a higher prevalence of radiation necrosis, indicating a need for careful patient selection and management.
	\|book_text=Proton Beam Therapy (PBT) represents a more targeted form of radiation therapy for glioblastoma, distinguished by its use of protons instead of traditional photons. This method allows for precise targeting of the tumor, minimizing damage to surrounding brain tissue. Research indicates that high-dose PBT can offer significant survival advantages over conventional radiation therapy, although it comes with a higher risk of radiation necrosis. Recent studies have explored the efficacy and safety of PBT, highlighting its potential to improve patient outcomes while also noting the importance of addressing associated toxic...		\|book_text=Proton Beam Therapy (PBT) represents a more targeted form of radiation therapy for glioblastoma, distinguished by its use of protons instead of traditional photons. This method allows for precise targeting of the tumor, minimizing damage to surrounding brain tissue. Research indicates that high-dose PBT can offer significant survival advantages over conventional radiation therapy, although it comes with a higher risk of radiation necrosis. Recent studies have explored the efficacy and safety of PBT, highlighting its potential to improve patient outcomes while also noting the importance of addressing associated toxic...
	}}		}}

Lazy: Created page with "{{TreatmentInfo |drug_name=Proton Beam Therapy (PBT) |FDA_approval=Yes |used_for=Glioblastoma and other cancers |clinical_trial_phase=Ongoing research and clinical trials |common_side_effects=Radiation dermatitis, temporary alopecia, radiation otitis, radiation necrosis (more prevalent in PBT group) |OS_without=Data varies; traditional radiation therapies offer median OS of around 16-21 months for glioblastoma |OS_with=High-dose PBT showed a median OS of 65.6 months for..."

2024-03-29T16:59:48Z

Created page with "{{TreatmentInfo |drug_name=Proton Beam Therapy (PBT) |FDA_approval=Yes |used_for=Glioblastoma and other cancers |clinical_trial_phase=Ongoing research and clinical trials |common_side_effects=Radiation dermatitis, temporary alopecia, radiation otitis, radiation necrosis (more prevalent in PBT group) |OS_without=Data varies; traditional radiation therapies offer median OS of around 16-21 months for glioblastoma |OS_with=High-dose PBT showed a median OS of 65.6 months for..."

New page

{{TreatmentInfo
|drug_name=Proton Beam Therapy (PBT)
|FDA_approval=Yes
|used_for=Glioblastoma and other cancers
|clinical_trial_phase=Ongoing research and clinical trials
|common_side_effects=Radiation dermatitis, temporary alopecia, radiation otitis, radiation necrosis (more prevalent in PBT group)
|OS_without=Data varies; traditional radiation therapies offer median OS of around 16-21 months for glioblastoma
|OS_with=High-dose PBT showed a median OS of 65.6 months for patients with radiation necrosis, and 26.9 months for patients without radiation necrosis in specific studies
|PFS_without=Standard radiation therapy PFS rates are lower compared to PBT
|PFS_with=Improved PFS observed with PBT, specific rates vary by study
|usefulness_rating=4 (Based on potential for increased survival and precision in targeting tumors while sparing surrounding tissue)
|toxicity_level=3 (Higher incidence of radiation necrosis noted, which may require surgical intervention or medical treatment with bevacizumab)
|toxicity_explanation=While acute radiation-related toxicities were equivalent to conventional radiation therapy, PBT has a higher prevalence of radiation necrosis, indicating a need for careful patient selection and management.
|book_text=Proton Beam Therapy (PBT) represents a more targeted form of radiation therapy for glioblastoma, distinguished by its use of protons instead of traditional photons. This method allows for precise targeting of the tumor, minimizing damage to surrounding brain tissue. Research indicates that high-dose PBT can offer significant survival advantages over conventional radiation therapy, although it comes with a higher risk of radiation necrosis. Recent studies have explored the efficacy and safety of PBT, highlighting its potential to improve patient outcomes while also noting the importance of addressing associated toxic...
}}